Summary:
- The article details the publication of Phase 1 clinical trial data for DARE-HRT1, an investigational intravaginal ring designed to deliver bio-identical estradiol and progesterone for hormone replacement therapy.
- The peer-reviewed findings, published in the journal *Menopause*, confirm the pharmacokinetic profile and safety of the delivery system, supporting its potential as a non-daily therapeutic option for menopausal symptoms.